NOVO NORDISK RESEARCH AND DEVELOPMENT UK LIMITED
Get an alert when NOVO NORDISK RESEARCH AND DEVELOPMENT UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-28 (this month)
Last made up 2025-05-14
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£19M
+19.1% vs 2023
Employees
150
+47.1% vs 2023
Profit before tax
£3M
+40.3% vs 2023
Name history
Renamed 2 times since incorporation — the current trading name was adopted 2026-02-02
- NOVO NORDISK RESEARCH AND DEVELOPMENT UK LIMITED 2026-02-02 → present
- NOVO NORDISK RESEARCH CENTRE OXFORD LIMITED 2022-06-14 → 2026-02-02
- ZIYLO LTD 2014-05-14 → 2022-06-14
Net assets
2-year trend · vs Technology median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £28,344,000 | £38,034,000 | |
| Operating profit | £2,366,000 | £3,285,000 | |
| Profit before tax | £2,385,000 | £3,347,000 | |
| Net profit | £1,688,000 | £1,875,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £19,515,000 | £56,979,000 | |
| Net assets | £15,750,000 | £18,756,000 | |
| Equity | £15,750,000 | £18,756,000 | |
| Average employees | 102 | 150 | |
| Wages | £10,882,000 | £17,075,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 8.3% | 8.6% | |
| Net margin | 6.0% | 4.9% | |
| Return on capital employed | 12.1% | 5.8% | |
| Interest cover | 22.32x | 14.04x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“These financial statements are prepared on a going concern basis. Novo Nordisk A/S, the ultimate holding company, has confirmed its financial support and capacity to provide continuing financial support for a minimum of 12 months from the date of signing the audit report, enabling the company to pay its debts as they fall due.”
Significant events
- “On the 20 February 2025, the company received a £3,100k cash injection in exchange for 3,100k £1 ordinary shares, at par being initial funding of an Oxford expansion project related to developing new office and lab space in Oxford for sole use by the company.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ROBINSON, Elizabeth | Secretary | 2025-05-15 | — | — |
| KARLSSON, Tore | Director | 2022-11-08 | Sep 1980 | Danish |
| PATEL, Mishal | Director | 2025-05-04 | Mar 1983 | British |
| RASMUSSEN, Mads Frederik | Director | 2022-11-08 | Sep 1970 | Danish |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| O'FLYNN, Matthew | Secretary | 2018-08-16 | 2024-10-15 |
| SMART, Thomas | Secretary | 2014-05-14 | 2018-08-16 |
| BAILEY, Nicholas James | Director | 2018-10-24 | 2022-11-08 |
| CHAPMAN, Andrew, Dr | Director | 2017-12-13 | 2018-08-16 |
| CONDE-KNAPE, Avelina Karin | Director | 2022-11-08 | 2025-09-10 |
| DAVIS, Anthony, Professor | Director | 2014-11-17 | 2018-08-16 |
| DESTECROIX, Harry, Dr | Director | 2014-05-14 | 2018-08-16 |
| HAAGEN, Tomas | Director | 2021-11-22 | 2022-11-08 |
| HAYNES, William Geoffrey | Director | 2021-11-22 | 2026-05-01 |
| MACDONALD, Keith | Director | 2014-11-17 | 2018-08-16 |
| PETERSEN, Jacob Sten | Director | 2018-08-16 | 2018-10-24 |
| SAHOTA, Pinder | Director | 2018-10-24 | 2022-11-08 |
| SCHINDLER, Marcus | Director | 2018-08-16 | 2021-11-19 |
| SMART, Thomas | Director | 2014-05-14 | 2018-08-16 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Novo Nordisk Region Europe A/S | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-08-16 | Ceased 2018-08-16 |
| Novo Nordisk A/S | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-08-16 | Active |
| Dr Harry Destecroix | Individual | Shares 25–50% | 2016-06-30 | Ceased 2017-09-14 |
Filing timeline
Last 20 of 104 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-02-02 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-05 | TM01 | officers | Termination director company with name termination date | |
| 2026-02-02 | CERTNM | change-of-name | Certificate change of name company | |
| 2025-09-22 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-19 | AA | accounts | Accounts with accounts type full | |
| 2025-06-05 | ANNOTATION | miscellaneous | Legacy | |
| 2025-05-29 | AD02 | address | Change sail address company with old address new address | |
| 2025-05-28 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-05-28 | CH01 | officers | Change person director company with change date | |
| 2025-05-20 | CH01 | officers | Change person director company with change date | |
| 2025-05-20 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-05-07 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-24 | SH01 | capital | Capital allotment shares | |
| 2024-10-15 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-09-26 | CH01 | officers | Change person director company with change date | |
| 2024-06-24 | AA | accounts | Accounts with accounts type full | |
| 2024-05-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-28 | AD02 | address | Change sail address company with old address new address | |
| 2023-09-28 | AA | accounts | Accounts with accounts type full | |
| 2023-05-25 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-11-11 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 11
- Capital events
- 1
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+34.2%
£28,344,000 £38,034,000
-
Cash
—
Not reported
-
Net assets
+19.1%
£15,750,000 £18,756,000
-
Employees
+47.1%
102 150
-
Operating profit
+38.8%
£2,366,000 £3,285,000
-
Profit before tax
+40.3%
£2,385,000 £3,347,000
-
Wages
+56.9%
£10,882,000 £17,075,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers